42 results on '"Velásquez, Gustavo E."'
Search Results
2. Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru
3. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis
4. Outcomes of a Career Development Program for Underrepresented Minority Investigators in the AIDS Clinical Trials Group
5. Experience with 4-month rifapentine and moxifloxacin-based tuberculosis treatment in San Francisco
6. Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
7. Experience With Four-Month Rifapentine and Moxifloxacin–Based Tuberculosis Treatment in San Francisco.
8. Recent advances in the treatment of tuberculosis
9. Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru
10. Promise and Peril of Pretomanid–Rifamycin Regimens for Drug-susceptible Tuberculosis
11. Additional file 1 of Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru
12. Recent advances in the treatment of tuberculosis
13. Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review
14. Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review
15. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru
16. Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death
17. Disparities in SARS-CoV-2 Vaccination-to-Infection Risk During the COVID-19 Pandemic in Massachusetts
18. Prevalence of SARS-CoV-2 antibodies among market and city bus depot workers in Lima, Peru
19. Disparities in SARS-CoV-2 Vaccination-to-Infection Risk, Massachusetts 2020-2021
20. Disparities in SARS-CoV-2 Testing in Massachusetts During the COVID-19 Pandemic
21. SARS-CoV-2 Testing Disparities in Massachusetts
22. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Among Market and City Bus Depot Workers in Lima, Peru.
23. Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series
24. Delayed Relapse of Paracoccidioidomycosis in the Central Nervous System: A Case Report
25. Quantitative assessment of the activity of antituberculosis drugs and regimens
26. Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
27. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial
28. Making up the difference: ensuring the bioequivalence of fixed-dose combinations for tuberculosis
29. A Case of Disseminated Histoplasmosis in a Patient with Rheumatoid Arthritis on Abatacept
30. Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis
31. Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts
32. Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis
33. Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model
34. Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study
35. Clinical Relevance of Routine Pyrazinamide Drug Susceptibility Testing in Multidrug-Resistant Tuberculosis
36. Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study.
37. Scientific advances and the end of tuberculosis: a report from the LancetCommission on Tuberculosis
38. Targeted Drug-Resistance Testing Strategy for Multidrug-Resistant Tuberculosis Detection, Lima, Peru, 2005–2008
39. Reply to te Brake : Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
40. Percent of lung involved in disease on chest X-ray predicts unfavorable treatment outcome in pulmonary tuberculosis.
41. Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized, Controlled Clinical Trial.
42. SARS-CoV-2 Testing Disparities in Massachusetts.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.